Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Get Rating) has been given a consensus rating of “Hold” by the nine ratings firms that are covering the firm, reports Marketbeat.com. One equity research analyst has rated the stock with a sell recommendation, four
Crown Heights House With Garage, Oriel Asks $2.499 Million
While there are only a handful of interior photos to provide a glimpse of original details, this Crown Heights townhouse offers a generous amount of space and is part of an architecturally intriguing block. The semi-detached house at 1441 Union
